| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $605.2M | +18.8% |
| Cost of Revenue | $137.2M | +6.9% |
| Gross Profit | $468.0M | +22.8% |
| R&D Expense | $209.6M | -6.0% |
| SG&A Expense | $189.8M | +15.7% |
| Operating Income | -$170.5M | +26.8% |
| Interest Expense | $11.7M | +137.7% |
| Pre-tax Income | -$131.2M | +31.6% |
| Income Tax | $37.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $163.8M | -32.0% |
| Accounts Receivable | $74.2M | +21.2% |
| Inventory | $35.1M | -8.0% |
| Current Assets | $1.11B | +7.0% |
| Total Assets | $1.24B | +8.3% |
| Current Liabilities | $756.4M | +322.3% |
| Long-term Debt | $97.3M | -82.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.4M | +64.0% |
| Capital Expenditures | $42.9M | +58.2% |
| Investing Cash Flow | -$140.2M | -176.2% |
| Financing Cash Flow | $90.3M | +472.1% |
| Free Cash Flow | -$69.2M | +31.1% |
| +144.8% |
| Net Income | -$168.6M | +18.6% |
| EPS (Basic) | -$1.56 | +20.0% |
| EPS (Diluted) | -$1.56 | +20.0% |
| Total Liabilities |
| $880.6M |
| +12.4% |
| Stockholders' Equity | $360.2M | -0.6% |